| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
54,251 |
42,613 |
$3.91M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,988 |
24,985 |
$973K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
21,872 |
13,084 |
$366K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,803 |
4,541 |
$225K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,599 |
3,879 |
$213K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,292 |
3,612 |
$155K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,450 |
2,626 |
$128K |
| 90832 |
Psychotherapy, 30 minutes with patient |
5,382 |
2,142 |
$110K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,767 |
449 |
$72K |
| 92557 |
|
3,794 |
2,393 |
$53K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,734 |
1,017 |
$53K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,116 |
874 |
$28K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,824 |
1,906 |
$25K |
| 90834 |
Psychotherapy, 45 minutes with patient |
293 |
107 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
698 |
437 |
$8K |
| 99188 |
|
1,291 |
645 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
756 |
463 |
$5K |
| 90686 |
|
6,202 |
3,866 |
$3K |
| 99177 |
|
520 |
301 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
500 |
319 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
61 |
39 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
32 |
24 |
$2K |
| 99381 |
|
145 |
110 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
213 |
130 |
$2K |
| 81002 |
|
1,414 |
813 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
413 |
267 |
$1K |
| 81025 |
|
253 |
133 |
$873.96 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
50 |
38 |
$778.62 |
| 82962 |
|
757 |
489 |
$744.98 |
| 99383 |
|
22 |
12 |
$678.70 |
| 90670 |
|
3,795 |
2,314 |
$548.47 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33 |
25 |
$284.34 |
| 90723 |
|
2,065 |
1,276 |
$241.81 |
| 90710 |
|
736 |
495 |
$237.09 |
| 90473 |
|
23 |
13 |
$223.52 |
| 90647 |
|
2,018 |
1,258 |
$221.79 |
| 90633 |
|
1,011 |
671 |
$204.65 |
| 90651 |
|
380 |
277 |
$30.40 |
| 90734 |
|
131 |
93 |
$10.11 |
| 90680 |
|
172 |
163 |
$10.00 |
| 90681 |
|
372 |
205 |
$0.62 |
| 90619 |
|
130 |
83 |
$0.28 |
| 90697 |
|
480 |
290 |
$0.17 |
| 90696 |
|
115 |
89 |
$0.13 |
| 90715 |
|
48 |
32 |
$0.13 |
| 90672 |
|
29 |
16 |
$0.12 |
| 3079F |
|
3,855 |
2,188 |
$0.02 |
| 1159F |
|
22,200 |
10,921 |
$0.02 |
| 1160F |
|
22,251 |
10,938 |
$0.02 |
| 3074F |
|
19,872 |
10,923 |
$0.01 |
| 3075F |
|
1,236 |
719 |
$0.01 |
| 3077F |
|
468 |
276 |
$0.01 |
| 3078F |
|
17,250 |
9,511 |
$0.01 |
| 1036F |
|
16,812 |
8,892 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
412 |
294 |
$0.00 |
| 3008F |
|
28,461 |
15,239 |
$0.00 |
| 1034F |
|
1,366 |
811 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
992 |
502 |
$0.00 |
| 1035F |
|
196 |
101 |
$0.00 |
| 90677 |
|
88 |
88 |
$0.00 |
| 92551 |
|
1,424 |
975 |
$0.00 |
| 3080F |
|
276 |
156 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
700 |
391 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
19 |
12 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
24 |
12 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
22 |
12 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,076 |
1,184 |
$0.00 |
| 90685 |
|
166 |
158 |
$0.00 |
| 99173 |
|
1,283 |
894 |
$0.00 |
| 3725F |
|
12,955 |
5,563 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
657 |
365 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,428 |
2,198 |
$0.00 |
| 4004F |
|
19 |
12 |
$0.00 |
| 90671 |
|
128 |
75 |
$0.00 |
| 90700 |
|
54 |
46 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
31 |
16 |
$0.00 |